mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.1 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |